NeoGenomics: Q1 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Monday reported a loss of $30.8 million in its first quarter.

The Fort Myers, Florida-based company said it had a loss of 25 cents per share. Losses, adjusted for amortization costs and stock option expense, were 9 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The operator of cancer-focused testing laboratories posted revenue of $137.2 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $126.3 million.

NeoGenomics expects full-year revenue in the range of $545 million to $555 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO

Advertisement

Recommended Stories